Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial. - Pagano G; Monnet A; Reyes A; Ribba B; Svoboda H; Kustermann T; Simuni T; Postuma RB; Pavese N; Stocchi F; Brockmann K; Smigorski K; et al. (Nature medicine, 2024)